Abstract
ELIXIR, the European life science infrastructure for biological information, is a unique initiative to consolidate Europe's national centres, services, and core bioinformatics resources into a single, coordinated infrastructure. ELIXIR brings together Europe's major life-science data archives and connects these with national bioinformatics infrastructures - the ELIXIR Nodes. This editorial introduces the ELIXIR channel in F1000Research; the aim of the channel is to collect and present ELIXIR's scientific and operational output, engage with the broad life science community and encourage discussion on proposed infrastructure solutions. Submissions will be assessed by the ELIXIR channel Editorial Board to ensure they are relevant to ELIXIR community, and subjected to F1000Research open peer review process.
Highlights
Open data has long been the norm in molecular biology and genomics, and the major biomolecular archives and databases are accessed by thousands of scientists every day
Review process Submissions to the ELIXIR Channel will first pass through the initial quality check by F1000Research editors and forwarded to the ELIXIR Editorial Board
The Board will make sure that the article is relevant to ELIXIR and within its scope; if approved, the article will be published in the ELIXIR channel and opened for the F1000Research peer review
Summary
Open data has long been the norm in molecular biology and genomics, and the major biomolecular archives and databases are accessed by thousands of scientists every day. ELIXIR, the European Research Infrastructure for biological data, represents our collective efforts to coordinate data flows and sustain these vital data resources. ELIXIR brings together Europe’s major life-science data archives (including EMBL-EBI) and, for the first time, connects these with national bioinformatics infrastructures and resources.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.